» Authors » Bert van der Vegt

Bert van der Vegt

Explore the profile of Bert van der Vegt including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 135
Citations 1821
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Poelhekken K, Dorrius M, Dibden A, Duffy S, van der Vegt B, de Bock G, et al.
Breast Cancer Res Treat . 2025 Feb; PMID: 40021589
Purpose: To develop a novel simulation model for ductal carcinoma in situ (DCIS), fully validate it, and provide new estimates for DCIS in the setting of population-based biennial screening. Methods:...
2.
de Haan-Du J, Groenier K, Kleefstra N, van der Vegt B, Siesling S, Landman G, et al.
BMJ Public Health . 2025 Feb; 2(1):e000050. PMID: 40018189
Introduction: Disparities in cancer stage appear to exist by socioeconomic status (SES) in the Netherlands. We evaluated the association of SES and cancer stage among patients with type 2 diabetes...
3.
Scholman C, Westra J, Zwakenberg M, Wedman J, van der Vegt B, Steenbakkers R, et al.
Clin Otolaryngol . 2025 Feb; PMID: 39952630
Objectives: Early detection of local recurrences in patients with head and neck squamous cell carcinoma (HNSCC) is crucial for long-term survival. Aim of this study was to compare white light...
4.
Shimelash M, Sidorenkov G, van der Vegt B, Jalving M, Racz E, de Bock G
Cancer Epidemiol Biomarkers Prev . 2025 Jan; PMID: 39820297
Background: Skin-cancers are the most common cancers in Caucasians, and their incidence is rising. Although metabolic and anthropometric markers play a role in cancer development, the relationship of metabolic and...
5.
van der Aa P, Witjes M, van der Vegt B, Schuuring E, Boeve K, Sidorenkov G, et al.
Oral Dis . 2024 Dec; PMID: 39737774
Objectives: This study aimed to explore differences in demographics, tumour characteristics and outcomes in oral squamous cell carcinoma (OSCC) patients with a history of non-smoking, non-drinking (NSND) versus smoking and/or...
6.
Nakshbandi U, Liefers S, Arends S, Spijkervet F, Verstappen G, Vissink A, et al.
Clin Exp Rheumatol . 2024 Dec; 42(12):2362-2368. PMID: 39699866
Objectives: This study aimed to assess (1) effects of abatacept on salivary gland histology of Sjögren's disease (SjD) patients, (2) the predictive value of salivary gland histopathological characteristics at baseline...
7.
Pringle S, Bikker F, Vogel W, de Bakker B, Hofland I, van der Vegt B, et al.
Radiother Oncol . 2024 Nov; :109959. PMID: 39492512
No abstract available.
8.
Eisses B, van Geel J, Brouwers A, Bensch F, Elias S, Kuip E, et al.
J Nucl Med . 2024 Sep; 65(10):1540-1547. PMID: 39237347
Understanding which patients with human epidermal growth factor receptor 2 (HER2)-negative or -low metastatic breast cancer (MBC) benefit from HER2-targeted strategies is urgently needed. We assessed the whole-body heterogeneity of...
9.
Legger G, Nakshbandi U, van Ginkel M, Liefers S, de Wolff L, Stel A, et al.
RMD Open . 2024 Aug; 10(3). PMID: 39142692
Objectives: The aim of this study was to assess the histopathological features of the parotid glands in patients with paediatric-onset Sjögren's disease (pedSjD) in comparison to patients with adult-onset Sjögren's...
10.
Zwager M, Yu S, Buikema H, de Bock G, Ramsing T, Thagaard J, et al.
Histopathology . 2024 Aug; 86(2):204-213. PMID: 39104219
Aim: Manual detection and scoring of Ki67 hotspots is difficult and prone to variability, limiting its clinical utility. Automated hotspot detection and scoring by digital image analysis (DIA) could improve...